Celebrities' use of weight loss drugs like Ozempic and Wegovy has surged, including Sharon Osbourne and Elon Musk. However, ...
Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.
Ozempic is traditionally used as a treatment for type 2 diabetes (T2DM) to help patients manage blood sugar levels. However, ...
New industry rules require visual size checks or GP medical records for online fat jab purchases. The updated guidelines ...
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
A Nova radio host has admitted live on-air to taking a weight loss drug popular with celebrities that costs an arm and a leg ...
Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to a new study.
A gold-standard University College of London study found a type of weight-loss jab had no benefit in alleviating a condition that will affect one in 37 people in Britain in their lifetime.
Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...